pravastatin has been researched along with neopterin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aukrust, P; Gullestad, L; Hutten, B; Kastelein, JJ; Ose, L; Ridker, PM; Rifai, N; Rodenburg, J; Semb, AG; Ueland, T; Vissers, MN; Wiegman, A | 1 |
| Braunwald, E; Cannon, CP; Morrow, DA; Ray, KK; Rifai, N; Sabatine, MS; Shui, A | 1 |
| Braunwald, E; Cannon, CP; Morrow, DA; Nazer, B; Ray, KK; Scirica, B; Sloan, S | 1 |
| Atar, I; Aydınalp, A; Bozbaş, H; Konaş, D; Korkmaz, ME; Mermer, S; Müderrisoğlu, H; Ozin, B; Yıldırır, A | 1 |
3 trial(s) available for pravastatin and neopterin
| Article | Year |
|---|---|
Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.
Topics: Acute Disease; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Biomarkers; Coronary Artery Disease; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Monocytes; Neopterin; Pravastatin; Prognosis; Pyrroles; Risk Factors; Secondary Prevention; Survival Analysis | 2007 |
Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Heart Failure; Heptanoic Acids; Hospitalization; Humans; Male; Middle Aged; Neopterin; Pravastatin; Proportional Hazards Models; Pyrroles; Sensitivity and Specificity; Treatment Outcome | 2011 |
Pravastatin therapy fails to suppress post-PCI inflammatory response measured by serum neopterin and CRP levels.
Topics: Adult; Aged; Aged, 80 and over; Angina, Stable; Angioplasty, Balloon, Coronary; C-Reactive Protein; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Neopterin; Pravastatin; Premedication; Stents; Vasculitis | 2011 |
1 other study(ies) available for pravastatin and neopterin
| Article | Year |
|---|---|
Increased inflammatory markers in children with familial hypercholesterolaemia.
Topics: Adolescent; Anticholesteremic Agents; Biomarkers; Body Mass Index; C-Reactive Protein; CD40 Ligand; Child; Cholesterol, HDL; Cholesterol, LDL; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Neopterin; Pravastatin; Siblings; Solubility | 2006 |